Novo Nordisk A/S
Stocks making the biggest moves midday: Carrier, Johnson Controls, Chart Industries, Sarepta
Check out some of the companies making the biggest moves at midday: Carrier Global — The air conditioner manufacturer slid 10% after reporting in-line second quarter results. Management told analysts on a conference call that U.S. residential and light commercial sales are projected to decline by 10% in the second half due to lower volumes, according to […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, Whirlpool, Sarepta Therapeutics and more
Check out the companies making headlines before the bell. Chart Industries — Shares of the gas equipment manufacturer surged 16% after it agreed to be acquired by Baker Hughes for $13.6 billion. Chart Industries had previously been in merger talks with power equipment supplier Flowserve , which was last up 8%. Baker Hughes shares fell […]
Read More
Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were […]
Read More
This Indian pharma company sees a big opportunity in generic versions of weight-loss drugs
Dr. Reddy ‘s Laboratories is betting big on a new wave of growth fueled by a global demand for weight-loss drugs — by launching its own lower-cost version of semaglutide, the blockbuster ingredient behind Wegovy and Ozempic. The Indian pharmaceutical company plans to launch its generic version of the drug in 87 countries by 2026, […]
Read More
Healthy Returns: Researchers move closer to a universal cancer vaccine
Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A universal cancer vaccine – what once seemed like a pipe dream – may be inching closer to becoming reality. On […]
Read More
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives ‘hope’
A person holds a smartphone displaying the logo of SAP, a German multinational software corporation known for its enterprise resource planning solutions. Cheng Xin | Getty Images News | Getty Images German software giant SAP said Wednesday that U.S. tariff tensions were slowing down its customers’ decision-making, but that the Japan trade agreement announced Tuesday […]
Read More
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2021 when she was diagnosed with […]
Read More
Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, […]
Read More
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Cr | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another potential competitor to blockbuster obesity treatments from Eli Lilly and Novo Nordisk just showed positive data – but this time, […]
Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]
Read More